Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products. An InPharma commentary

Reppas, ChristosKuentz, MartinBauer-Brandl, AnnetteCarlert, SaraDallmann, AndréDietrich, ShirinDressman, JenniferEjskjaer, LotteFrechen, SebastianGuidetti, MatteoHolm, RenéHolzem, Florentin LukasKarlsson, ΕvaKostewicz, EdmundPanbachi, ShaidaPaulus, FelixSenniksen, Malte BøghStillhart, CordulaTurner, David B.Vertzoni, MariaVrenken, PaulZöller, LaurinGriffin, Brendan T.O'Dwyer, Patrick J.2023-09-082023-09-082023-09-010928-09871879-072010.1016/j.ejps.2023.106505https://irf.fhnw.ch/handle/11654/37942https://doi.org/10.26041/fhnw-5319en600 - Technik, Medizin, angewandte WissenschaftenLeveraging the use of in vitro and computational methods to support the development of enabling oral drug products. An InPharma commentary01A - Beitrag in wissenschaftlicher Zeitschrift